KPV 10

KPV 10

TARGETED PEPTIDE RESEARCH. SIMPLIFIED.

KPV is a short peptide consisting of three amino acids — lysine, proline and valine — derived from the naturally occurring α-melanocyte-stimulating hormone (α-MSH).

KPV has attracted research interest primarily because of its potential involvement in inflammatory signalling, immune responses, skin biology and gastrointestinal health. Much of this research remains preclinical, making KPV an emerging area of peptide research rather than an established therapeutic treatment.

Areas of Research Interest

KPV is being investigated in relation to:

• Inflammatory signalling pathways
• Immune-response modulation
• Gastrointestinal and intestinal-barrier research
• Skin and dermatological research
• Tissue-response mechanisms
• Cellular responses associated with inflammation

ImproHealth KPV 10

Each vial contains 10 mg KPV, supplied in lyophilised form for stability prior to reconstitution.

Product: KPV
Strength: 10 mg
Form: Lyophilised peptide
Storage: Store according to the instructions supplied with the product.

Important Information

KPV is an investigational peptide and its potential therapeutic applications have not been established through the level of clinical evidence required for approved medicines. Research findings should not be interpreted as evidence that KPV can prevent, diagnose or treat inflammatory, gastrointestinal, skin or other medical conditions.

ImproHealth
ENHANCE. OPTIMISE. THRIVE.